- MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA — not nuclear DNA. This was paradigm-shifting.
- It acts as a retrograde signal from mitochondria to the cell nucleus, regulating metabolic homeostasis.
- MOTS-c activates AMPK, improves insulin sensitivity, and promotes glucose uptake in skeletal muscle.
- Called an "exercise mimetic" because it produces some metabolic benefits of physical exercise.
- MOTS-c levels decline with age and are lower in individuals with obesity and insulin resistance.
The Paradigm Shift
Mitochondria were "the powerhouse of the cell" — organelles making ATP. Their tiny genome (16,569 base pairs) was thought to code exclusively for respiratory chain components. In 2001, Pinchas Cohen's group at USC discovered humanin, a peptide hidden in mitochondrial rRNA genes. In 2015, they found MOTS-c.
These discoveries reframed mitochondria from passive power plants to active signaling organelles producing peptide hormones that communicate with the rest of the cell and other organs.
What Is MOTS-c?
MOTS-c is a 16-amino-acid peptide encoded within the 12S rRNA gene. It's produced inside mitochondria, translocated to the cell nucleus (directly regulating gene expression), and secreted into the bloodstream as a circulating hormone.
Levels are highest in skeletal muscle and plasma, decline with age (roughly 50% between age 20 and 70), and are inversely correlated with metabolic dysfunction.
How It Works
MOTS-c activates AMPK (the master metabolic sensor), triggering increased glucose uptake, enhanced fatty acid oxidation, and improved insulin sensitivity. Under metabolic stress, MOTS-c translocates to the nucleus and activates antioxidant response elements, adjusting gene expression based on the mitochondria's metabolic state.
This retrograde signaling — from mitochondria to nucleus — was essentially unknown before mitochondrial-derived peptides were discovered.
The Exercise Mimetic
MOTS-c parallels exercise in several ways: AMPK activation, increased glucose uptake, improved insulin sensitivity, enhanced fatty acid oxidation, and mitochondrial biogenesis. In mice, MOTS-c improved exercise capacity, prevented diet-induced obesity, and reversed age-related insulin resistance.
Exercise itself increases MOTS-c levels. Physically fit individuals have chronically elevated MOTS-c. The peptide may be one of the molecular mediators of exercise's metabolic benefits.
Nobody suggests MOTS-c replaces exercise. But for populations that can't exercise sufficiently, a peptide activating similar pathways is potentially transformative.
Aging and Mitochondria
Mitochondrial dysfunction is a hallmark of aging. If MOTS-c levels decline with age and MOTS-c is important for metabolic homeostasis, the decline may contribute to age-related metabolic deterioration: insulin resistance, fat accumulation, reduced exercise tolerance.
Restoring MOTS-c levels in aged animals improves multiple metabolic parameters. Whether this translates to humans is the open question.
Where Research Stands
We know: The mechanism is well-characterized in cell culture and animal models. Metabolic effects in mice are consistent. Age-related decline is documented. The exercise connection is established.
We don't know: Optimal human dosing. Long-term safety. Whether exogenous MOTS-c reaches the same intracellular compartments as endogenous MOTS-c. Human clinical trials are early-stage.
MOTS-c represents one of the most exciting peptides of the past decade. The biology is novel, the therapeutic potential significant, and the field wide open.
References
- Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. PubMed
- Kim KH, et al. MOTS-c: An equal opportunity insulin sensitizer. J Mol Med. 2019;97(4):487-490. PubMed
- Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470. PubMed
- Lu H, et al. MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction. J Mol Med. 2019;97(4):473-485. PubMed